Evidence map›Paper›PMID 28057865›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Cocapture of cognate and bystander antigens can activate autoreactive B cells.

Nicholas S R Sanderson, Maria Zimmermann, Luca Eilinger, Céline Gubser, Nicole Schaeren-Wiemers, Raija L P Lindberg, Stephanie K Dougan, Hidde L Ploegh, Ludwig Kappos, Tobias Derfuss

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. The persistent inflammation in COPD: is autoimmunity the core mechanism?European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  7. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Autoantibodies in neurological disease.Nature reviews. Immunology · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Nicholas S R SandersonDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland; nicholas.sanderson@unibas.ch tobias.derfuss@usb.ch.
Maria ZimmermannDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Luca EilingerDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Céline GubserDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Nicole Schaeren-WiemersDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Raija L P LindbergDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Stephanie K DouganWhitehead Institute for Biomedical Research, Cambridge, MA 02142.
Hidde L PloeghWhitehead Institute for Biomedical Research, Cambridge, MA 02142.
Ludwig KapposDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Tobias DerfussDepartment of Biomedicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland; nicholas.sanderson@unibas.ch tobias.derfuss@usb.ch.
University of Basel · CHUniversity Hospital of Basel · CHWhitehead Institute for Biomedical Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoantibodies against myelin oligodendrocyte glycoprotein (MOG) are associated with autoimmune central nervous system diseases like acute disseminated encephalomyelitis (ADEM). For ADEM, it is speculated that a preceding infection is the trigger of the autoimmune response, but the mechanism connecting the infection to the production of MOG antibodies remains a mystery. We reasoned that the ability of B cells to capture cognate antigen from cell membranes, along with small quantities of coexpressed "bystander" antigens, might enable B-cell escape from tolerance. We tested this hypothesis using influenza hemagglutinin as a model viral antigen and transgenic, MOG-specific B cells. Using flow cytometry and live and fixed cell microscopy, we show that MOG-specific B cells take up large amounts of MOG from cell membranes. Uptake of the antigen from the membrane leads to a strong activation of the capturing B cell. When influenza hemagglutinin is also present in the membrane of the target cell, it can be cocaptured with MOG by MOG-specific B cells via the B-cell receptor. Hemagglutinin and MOG are both presented to T cells, which in turn are activated and proliferate. As a consequence, MOG-specific B cells get help from hemagglutinin-specific T cells to produce anti-MOG antibodies. In vivo, the transfer of MOG-specific B cells into recipient mice after the cocapture of MOG and hemagglutinin leads to the production of class-switched anti-MOG antibodies, dependent on the presence of hemagglutinin-specific T cells. This mechanism offers a link between infection and autoimmunity.

Indexed as

AnimalsAntigens, ViralAutoantibodiesAutoantigensAutoimmunityB-LymphocytesCell LineCell MembraneHEK293 CellsHemagglutinin Glycoproteins, Influenza VirusHumansMiceMice, Inbred C57BLMyelin-Oligodendrocyte GlycoproteinReceptors, Antigen, B-CellT-LymphocytesAntigens, ViralAutoantibodiesAutoantigensHemagglutinin Glycoproteins, Influenza VirusMyelin-Oligodendrocyte GlycoproteinReceptors, Antigen, B-Cellantigen captureantigen presentationautoantibodiesinfluenzatolerance

Identifiers

PMID28057865
PMCPMC5278454
OpenAlexW2571533957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.